UBE3A and osteosarcoma: Whereas we did not observe pro-senescent effects following E6AP silencing in HPV-negative, p53 wildtype RKO and HCT116 colon cancer cells, or U2OS osteosarcoma cells, it was reported that E6AP has pro- or anti-senescent effects in certain cell lines [56,62,63].